Kerrisdale Advisers, LLC Arbutus Biopharma Corp Transaction History

Kerrisdale Advisers, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 14, 2022	SELL	$3.11 - $4.61 $311,000 - $461,000	-100,000 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$2.65 - $4.62 $265,000 - $462,000	100,000 New	100,000 $429,000
Q2 2021 Aug 16, 2021	SELL	$2.5 - $3.51 $520,375 - $730,606	-208,150 Closed	0 $0
Q1 2021 May 17, 2021	BUY	$3.14 - $4.84 $653,591 - $1.01 Million	208,150 New	208,150 $693,000

138

95.5M

3.44M

377K

Ticker ABUS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 149,951,008
Market Cap $577M
Description
Arbutus Biopharma Corporation, a biopharmaceutical company, develops novel therapeutics for chronic Hepatitis B virus (HBV) infection, SARS-CoV-2, and other coronaviruses in the United States. Its HBV product pipeline consists of AB-729, a proprietary subcutaneously delivered RNA interference product candidate, which in Phase Ia/Ib clinical tria...

Get notified when there are updates to the investment portfolio of Kerrisdale Advisers, LLC, based on Form 13F filings with the SEC.

Stay updated on Kerrisdale Advisers, LLC with notifications on news.